superDimension, a private company that develops minimally invasive interventional pulmonology devices, has completed a round of private equity financing totaling $22.3 million.
Subscribe to our email newsletter
The company’s first product, the inReach System, provides minimally invasive electromagnetic navigation (similar to GPS) to distant regions of the lungs, enabling doctors to diagnose lung cancer at earlier stages and potentially provide more timely treatment.
Daniel Sullivan, president and CEO of superDimension, said: “This round of financing will accelerate the company’s investment in sales and marketing to meet and accelerate the growing worldwide demand for inReach.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.